Every year 10 million patients in Europe benefit from nuclear medicine. In the past decade, research has made tremendous progress and medical isotopes are expected to become an even more vital tool in the treatment of many types of cancers.
In this session, we will learn about the use of medical isotopes for diagnosis and treatment. Our experts will give an update on increasingly effective therapeutics and the expected growth in medical nuclear procedures in line with these dynamic developments.
We will identify what is needed to establish a robust supply chain in the EU and to ensure that all patients receive the care they need when they need it.
- Dr. Wouter Vogel, Antoni Van Leeuwenhoek Dutch Cancer Institute
- Prof. Michel Koole, European Association of Nuclear Medicine (EANM)
- Richard Zimmermann, MEDraysintell, and Sven Van den Berghe, Panthera
Moderator: Remigiusz Baranczyk, Euratom Supply Agency
You can attend the event on-site or via live streaming. It is free of charge, but we ask you for registering:
On-Site Participation: Please, select the On-Site Participation Ticket (max. 30 seats available)
Live Streaming: Please, register for a Live Streaming Ticket (starting from 09:00am)